The pharma trends leading to higher demand for CDMOs
Recent discoveries and advances in pharma for lower demand illnesses/indications have resulted in an increase in the number of smaller start-up organisations. The focus of pharma has shifted from high demand blockbusters to specialty pharma drugs with higher margins and smaller patient populations.